ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Dr. Charles Turck and Dr. Guru Sonpavde discuss findings from the IMvigor011 study presented at the 2026 ASCO Genitourinary Cancers Symposium. They explore how ctDNA monitoring in muscle-invasive bladder cancer (MIBC) can detect early recurrence, assess immunotherapy response…